These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 16285330)
1. Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002. Bennett K; Johnson H; Dack P; Shelley E; Feely J Ir J Med Sci; 2005; 174(3):4-8. PubMed ID: 16285330 [TBL] [Abstract][Full Text] [Related]
2. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India. Sharma KK; Gupta R; Agrawal A; Roy S; Kasliwal A; Bana A; Tongia RK; Deedwania PC Vasc Health Risk Manag; 2009; 5():1007-14. PubMed ID: 19997570 [TBL] [Abstract][Full Text] [Related]
3. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States. Stafford RS; Monti V; Furberg CD; Ma J Hypertension; 2006 Aug; 48(2):213-8. PubMed ID: 16785334 [TBL] [Abstract][Full Text] [Related]
4. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Xie JX; Gunzburger EC; Kaun L; Plomondon ME; BarĂ³n AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896 [TBL] [Abstract][Full Text] [Related]
5. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis. Hippisley-Cox J; Coupland C BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390 [TBL] [Abstract][Full Text] [Related]
6. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction. Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577 [TBL] [Abstract][Full Text] [Related]
7. Under-prescribing of cardiovascular therapies for diabetes in primary care. Bennett KE; Williams D; Feely J Eur J Clin Pharmacol; 2003 Apr; 58(12):835-41. PubMed ID: 12698311 [TBL] [Abstract][Full Text] [Related]
8. ACE up the sleeve - are vascular patients medically optimized? Coveney AP; O'Brien GC; Fulton GJ Vasc Health Risk Manag; 2011 Jan; 7():15-21. PubMed ID: 21339909 [TBL] [Abstract][Full Text] [Related]
9. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS]. Yahia DH; Pereg D; Lishner M; Elis A Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639 [TBL] [Abstract][Full Text] [Related]
10. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. Williams D; Bennett K; Feely J Br J Clin Pharmacol; 2003 Jun; 55(6):604-8. PubMed ID: 12814456 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease. Sharma KK; Mathur M; Gupta R; Guptha S; Roy S; Khedar RS; Gupta N; Gupta R Indian Heart J; 2013; 65(3):250-5. PubMed ID: 23809376 [TBL] [Abstract][Full Text] [Related]
12. Prescription of statins: cost implications of evidence-based treatment applied to a health authority population. Bradshaw N; Walker R J Clin Pharm Ther; 1997; 22(5-6):379-89. PubMed ID: 19160723 [TBL] [Abstract][Full Text] [Related]
13. Age, sex and practice variations in the use of statins in general practice in England and Wales. Majeed A; Moser K; Maxwell R J Public Health Med; 2000 Sep; 22(3):275-9. PubMed ID: 11077897 [TBL] [Abstract][Full Text] [Related]
14. Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland. Bennett KE; Williams D; Feely J Ir Med J; 2002 Jun; 95(6):169-72. PubMed ID: 12171263 [TBL] [Abstract][Full Text] [Related]
15. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. Berger AK; Duval S; Krumholz HM J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751 [TBL] [Abstract][Full Text] [Related]
16. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction. Kizer JR; Cannon CP; McCabe CH; Mueller HS; Schweiger MJ; Davis VG; Perritt R; Antman EM Am Heart J; 1999 Jan; 137(1):79-92. PubMed ID: 9878939 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home. Joseph J; Koka M; Aronow WS J Am Med Dir Assoc; 2008 Feb; 9(2):124-7. PubMed ID: 18261706 [TBL] [Abstract][Full Text] [Related]
18. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease. Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523 [TBL] [Abstract][Full Text] [Related]